// App-Quantinova.ai

4858 : LADRTM: A novel linker activated drug release technology for drug delivery

Researchers

Presenter

  • Khalid Abu Ajaj

Principal Investigators

  • Stephan David Koester

  • Friederike Inga Nollmann

  • Simon Waltzer

  • Olga Fuchs

  • Andre Warnecke

  • Felix Kratz

Medical Centers

  • CytRx Corporation, Freiburg, Germany.

Locations

  • Germany

Companies

  • CytRx Corp.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • INNO206

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A